buprenorphine (Q407721)

From Wikidata
Jump to navigation Jump to search
opioid used to treat opioid use disorder
  • Buprenex®
  • Temgesic®
  • (-)-buprenorphine
  • 21-cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
  • 2-(N-cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol
  • 17-cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
  • 21-cyclopropyl-7α-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
  • 2-(N-cyclopropylmethyl-4,5α-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6α-yl)-3,3-dimethyl-2-butanol
  • Buprenophine
  • Buprenorphinum
  • (−)-buprenorphine
  • 2-[3-cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol
  • Buprenorphine
  • 17-cyclopropylmethyl-4,5α-epoxy-7α-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
  • Buprenorfina
edit
Language Label Description Also known as
default for all languages
No label defined
    English
    buprenorphine
    opioid used to treat opioid use disorder
    • Buprenex®
    • Temgesic®
    • (-)-buprenorphine
    • 21-cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
    • 2-(N-cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol
    • 17-cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
    • 21-cyclopropyl-7α-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
    • 2-(N-cyclopropylmethyl-4,5α-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6α-yl)-3,3-dimethyl-2-butanol
    • Buprenophine
    • Buprenorphinum
    • (−)-buprenorphine
    • 2-[3-cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol
    • Buprenorphine
    • 17-cyclopropylmethyl-4,5α-epoxy-7α-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
    • Buprenorfina

    Statements

    0 references
    Buprenorphin.svg
    333 × 299; 31 KB
    0 references
    Buprenorphine.svg
    580 × 565; 22 KB
    0 references
    467.304 dalton
    1 reference
    C₂₉H₄₁NO₄
    1 reference
    CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O
    1 reference
    C[C@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)(C(C)(C)C)O
    1 reference
    1 reference
    1 reference
    1 reference
    1 reference
    1 reference
    FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)
    Buprenorphine
    0 references

    Identifiers

    0 references
    6182863
    1 reference
    buprenorphine (English)
    3 October 2016
    1 reference
    27 December 2018
    Buprenorphine (English)
    CAS no.: 52485-79-7 (English)
    Buprenorphine
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    1 reference
    buprenorphine (English)
    3 October 2016
    1 reference
    buprenorphine (English)
    3 October 2016
    0 references
    0 references
    0 references
     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit